Works from 2020
REPOCH compared with RCHOP for the treatment of diffuse large B-cell lymphoma of activated B-cell type, Phillip Martinez-Knouse, Edward Nabrinsky, Anjana Chandran, et al. (Abstract)
Highlighting survival with yttrium-90 radioembolization therapy in unresectable hepatocellular carcinoma, Edward Nabrinsky and Edward James (Article)
Development of inflammatory bowel disease (IBD) following the use of biologic treatment for rheumatologic diseases: A review of the Food and Drug Administration Adverse Event Reports System (FAERS), Saad Hashmi, Ryan Hoff, and Eli Ehrenpreis (Abstract)
Effect of intravenous odansetron in hospitalized patients on measured QTC interval, David H Kruchko, Eli Ehrenpreis, and Charles Broy (Article)
Gastroenterologists and infectious disease physicians are more attuned to appropriate ordering of the gastrointestinal pathogen panel, Saad Hashmi, Faisal Masood, Ryan Hoff, et al. (Abstract)
Acute hypersensitivity pneumonitis associated with a high Ki-67 proliferative index, Edward Nabrinsky, Amanda Kamar, Dereen Mohammed Saeed, et al. (Article)
Reporting trends of adverse effects from proton pump inhibitors to the food and drug administration, David H Kruchko, Ami P. Patel, Dana Villines, et al. (Article)
Cell death pathways in lymphoid malignancies, Luke Fletcher, Edward Nabrinsky, Tingting Liu, et al. (Article)
Percutaneous endoscopic jejunostomy tube placement for treatment of severe hyperemesis gravidarum in pregnancy, David H Kruchko, Natasha Shah, Charles Broy, et al. (Article)